Nuclear factor κB p65 phosphorylation in orthodontic tooth movement

被引:8
|
作者
Zuo, J. [1 ]
Archer, L. A. [1 ]
Cooper, A. [1 ]
Johnson, K. L. [1 ]
Holliday, L. S. [1 ]
Dolce, C. [1 ]
机构
[1] Univ Florida, Coll Dent, Dept Orthodont, Gainesville, FL 32610 USA
关键词
osteoclast; bone resorption; RANK; RAW; 264.7; osteoclastogenesis;
D O I
10.1177/154405910708600613
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Osteoclasts play a vital role in orthodontic tooth movement. Transactivation of nuclear factor kappa B (NF kappa B) by phosphorylation of the p65 component of NF kappa B at amino acid 536 (p65*(536)) plays a role in osteoclast differentiation stimulated by receptor activator of nuclear factor kappa B-ligand (RANK-L). We hypothesized that this transactivation pathway might be involved in the responses of alveolar bone cells during orthodontic tooth movement. We detected sharp increases in the levels of p65*(536) 3 and 12 hrs after the application of orthodontic stimuli in rats. In cell culture, osteoclast-like cells displayed no changes in p65*(536) in response to RANK-L, but levels rapidly increased after the cells were mechanically scraped. We conclude that p65*(536) is produced rapidly in response to orthodontic stimuli and mechanical insults, and may be important in bone remodeling associated with orthodontic tooth movement.
引用
收藏
页码:556 / 559
页数:4
相关论文
共 50 条
  • [41] Inhibition of p65 Nuclear Translocation by Baicalein
    Seo, Min Bum
    Lee, Seog Ki
    Jeon, Young Jin
    Im, Jin Su
    TOXICOLOGICAL RESEARCH, 2011, 27 (02) : 71 - 76
  • [42] Intranuclear delivery of synthetic nuclear factor-kappa B p65 reduces inflammasomes after surgery
    Cheon, So Yeong
    Kim, Jeong Min
    Kim, Eun Jung
    Kim, So Yeon
    Kam, Eun Hee
    Ho, Chun-Chang
    Lee, Sang-Kyou
    Koo, Bon-Nyeo
    BIOCHEMICAL PHARMACOLOGY, 2018, 158 : 141 - 152
  • [43] Increased nuclear factor-κB p65 immunoreactivity following retinal ischemia and reperfusion injury in mice
    Chen, YG
    Zhang, C
    Chiang, SKS
    Wu, TH
    Tso, MOM
    JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 72 (01) : 125 - 131
  • [44] Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor κB response
    Saccani, S
    Marazzi, I
    Beg, AA
    Natoli, G
    JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (01): : 107 - 113
  • [45] HSP70 mediates degradation of the p65 subunit of nuclear factor κB to inhibit inflammatory signaling
    Tanaka, Takashi
    Shibazaki, Azusa
    Ono, Rumiko
    Kaisho, Tsuneyasu
    SCIENCE SIGNALING, 2014, 7 (356)
  • [46] Expression and significance of nuclear factor κB p65 in colon tissues of rats with TNBS-induced colitis
    Li, Jun-Hua
    Yu, Jie-Ping
    Yu, Hong-Gang
    Xu, Xi-Ming
    Yu, Liang-Liang
    Liu, Shi-Quan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (12) : 1759 - 1763
  • [47] Ethyl pyruvate inhibits nuclear factor-κB-dependent signaling by directly targeting p65
    Han, YS
    Englert, JA
    Yang, RK
    Delude, RL
    Fink, MP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (03): : 1097 - 1105
  • [49] Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-κB transactivation
    Campbell, KJ
    Witty, JM
    Rocha, S
    Perkins, ND
    CANCER RESEARCH, 2006, 66 (02) : 929 - 935
  • [50] Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance
    Bu, Yiwen
    Cai, Guoshuai
    Shen, Yi
    Huang, Chenfei
    Zeng, Xi
    Cao, Yu
    Cai, Chuan
    Wang, Yuhong
    Huang, Dan
    Liao, Duan-Fang
    Cao, Deliang
    CANCER LETTERS, 2016, 383 (02) : 261 - 271